Handelsbanken Fonder’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $400K | Sell |
47,200
-13,500
| -22% | -$114K | ﹤0.01% | 1336 |
|
2025
Q1 | $488K | Hold |
60,700
| – | – | ﹤0.01% | 1246 |
|
2024
Q4 | $545K | Hold |
60,700
| – | – | ﹤0.01% | 1252 |
|
2024
Q3 | $445K | Buy |
60,700
+7,100
| +13% | +$52.1K | ﹤0.01% | 1297 |
|
2024
Q2 | $306K | Buy |
53,600
+20,100
| +60% | +$115K | ﹤0.01% | 1381 |
|
2024
Q1 | $168K | Buy |
33,500
+1,900
| +6% | +$9.53K | ﹤0.01% | 1530 |
|
2023
Q4 | $284K | Hold |
31,600
| – | – | ﹤0.01% | 1396 |
|
2023
Q3 | $246K | Hold |
31,600
| – | – | ﹤0.01% | 1377 |
|
2023
Q2 | $306K | Sell |
31,600
-3,800
| -11% | -$36.8K | ﹤0.01% | 1333 |
|
2023
Q1 | $388K | Hold |
35,400
| – | – | ﹤0.01% | 1135 |
|
2022
Q4 | $153K | Buy |
35,400
+9,900
| +39% | +$42.8K | ﹤0.01% | 1474 |
|
2022
Q3 | $192K | Hold |
25,500
| – | – | ﹤0.01% | 1445 |
|
2022
Q2 | $256K | Hold |
25,500
| – | – | ﹤0.01% | 1410 |
|
2022
Q1 | $316K | Hold |
25,500
| – | – | ﹤0.01% | 1490 |
|
2021
Q4 | $583K | Buy |
+25,500
| New | +$583K | ﹤0.01% | 1247 |
|